Glenmark Pharmaceuticals (Australia) Pty. Limited, is part of Glenmark Pharmaceuticals Limited, a research‐led, global pharmaceutical company, having a presence across branded, generics, and over-the-counter (OTC) segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 14 10 world‐class manufacturing facilities, spread across 4 continents, and operations in over 80 countries, spread across 5 continents.

Glenmark Pharmaceuticals started operations in Australia in 2018 and since then, it has been keeping patient at the centre of everything we they do,. At Glenmark, we are committed to providing high-quality affordable medicines in the this regions we operate in.

Glenmark Australia has a clear goal of being a market leader within the areas of Dermatologydermatology/ and Respiratory respiratory. areas.

By leveraging the global strength of Glenmark Pharmaceuticals in dermatology and respiratory, segments Glenmark Australia aims to significantly improve Australians people’s lives of people in Australia by aiming to creating ‘A new way for a new world’.

So far, Glenmark Australia has commercialized both innovative and generic products in this marketAustraliathe region, additionally, we will be launching prescription hospital products in the respective segments in the near future..

Country Manager Quote – “Australia is a key Mmarket for Glenmark. We have a really strong pipeline of medicines for various dermatology and respiratory conditions. We are dedicationed to enhancing the healthcare landscape in Australia by providing quality products that offer more choices to patients,” says Michael Moffitt, Country Manager at Glenmark.